カテゴリー： LP Information, 世界, 医療/バイオ

世界の組換え抗体（rAbs）市場予測 2021年-2026年

【英語タイトル】Global Recombinant Antibodies (rAbs) Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9565）・商品コード：LPI21MY9565
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：166
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「組換え抗体（rAbs）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、うさぎ、ねずみ、やぎ、その他など、用途別には、病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他などにセグメント区分してまとめました。組換え抗体（rAbs）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・組換え抗体（rAbs）の世界市場概要（サマリー）
・組換え抗体（rAbs）の企業別販売量・売上
・組換え抗体（rAbs）の企業別市場シェア
・組換え抗体（rAbs）の世界市場規模 2016年-2021年：種類別（うさぎ、ねずみ、やぎ、その他）
・組換え抗体（rAbs）の世界市場規模 2016年-2021年：用途別（病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他）
・組換え抗体（rAbs）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・組換え抗体（rAbs）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・組換え抗体（rAbs）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・組換え抗体（rAbs）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・組換え抗体（rAbs）市場の成長要因・課題・動向
・組換え抗体（rAbs）の世界市場予測 2021年-2026年
・組換え抗体（rAbs）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・組換え抗体（rAbs）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・組換え抗体（rAbs）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・組換え抗体（rAbs）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・組換え抗体（rAbs）の世界市場予測：種類別（うさぎ、ねずみ、やぎ、その他）
・組換え抗体（rAbs）の世界市場予測：用途別（病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Recombinant Antibodies (rAbs) will have significant change from previous year. By the most conservative estimates of global Recombinant Antibodies (rAbs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Recombinant Antibodies (rAbs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Antibodies (rAbs) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Rabbit
Mouse
Goat
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology
Research Institutes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Abcam
Abeomics
Abnova Corporation
Absolute Antibody
Activity Signaling
AIVD Biotech
Bio X Cell
BioLegend
Bio-Rad
Bon Opus Biosciences
Creative Biolabs
Creative Diagnostics
Enzo Life Sciences, Inc.
GRP GmbH
HUABIO
Miltenyi Biotec
NSJ Bioreagents
PROGEN
RevMab Biosciences USA, Inc.
Signalway Antibody LLC

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Antibodies (rAbs) Consumption 2016-2026
2.1.2 Recombinant Antibodies (rAbs) Consumption CAGR by Region
2.2 Recombinant Antibodies (rAbs) Segment by Type
2.2.1 Rabbit
2.2.2 Mouse
2.2.3 Goat
2.2.4 Others
2.3 Recombinant Antibodies (rAbs) Sales by Type
2.3.1 Global Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
2.3.2 Global Recombinant Antibodies (rAbs) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Recombinant Antibodies (rAbs) Sale Price by Type (2016-2021)
2.4 Recombinant Antibodies (rAbs) Segment by Application
2.4.1 Hospitals & Diagnostic Laboratories
2.4.2 Pharmaceutical & Biotechnology
2.4.3 Research Institutes
2.4.4 Others
2.5 Recombinant Antibodies (rAbs) Sales by Application
2.5.1 Global Recombinant Antibodies (rAbs) Sale Market Share by Application (2016-2021)
2.5.2 Global Recombinant Antibodies (rAbs) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Recombinant Antibodies (rAbs) Sale Price by Application (2016-2021)

3 Global Recombinant Antibodies (rAbs) by Company
3.1 Global Recombinant Antibodies (rAbs) Sales Market Share by Company
3.1.1 Global Recombinant Antibodies (rAbs) Sales by Company (2019-2021)
3.1.2 Global Recombinant Antibodies (rAbs) Sales Market Share by Company (2019-2021)
3.2 Global Recombinant Antibodies (rAbs) Revenue Market Share by Company
3.2.1 Global Recombinant Antibodies (rAbs) Revenue by Company (2019-2021)
3.2.2 Global Recombinant Antibodies (rAbs) Revenue Market Share by Company (2019-2021)
3.3 Global Recombinant Antibodies (rAbs) Sale Price by Company
3.4 Global Manufacturers Recombinant Antibodies (rAbs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Antibodies (rAbs) Product Location Distribution
3.4.2 Players Recombinant Antibodies (rAbs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Recombinant Antibodies (rAbs) by Region
4.1 Global Recombinant Antibodies (rAbs) by Region
4.1.1 Global Recombinant Antibodies (rAbs) Sales by Region
4.1.2 Global Recombinant Antibodies (rAbs) Revenue by Region
4.2 Americas Recombinant Antibodies (rAbs) Sales Growth
4.3 APAC Recombinant Antibodies (rAbs) Sales Growth
4.4 Europe Recombinant Antibodies (rAbs) Sales Growth
4.5 Middle East & Africa Recombinant Antibodies (rAbs) Sales Growth

5 Americas
5.1 Americas Recombinant Antibodies (rAbs) Sales by Country
5.1.1 Americas Recombinant Antibodies (rAbs) Sales by Country (2016-2021)
5.1.2 Americas Recombinant Antibodies (rAbs) Revenue by Country (2016-2021)
5.2 Americas Recombinant Antibodies (rAbs) Sales by Type
5.3 Americas Recombinant Antibodies (rAbs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Recombinant Antibodies (rAbs) Sales by Region
6.1.1 APAC Recombinant Antibodies (rAbs) Sales by Region (2016-2021)
6.1.2 APAC Recombinant Antibodies (rAbs) Revenue by Region (2016-2021)
6.2 APAC Recombinant Antibodies (rAbs) Sales by Type
6.3 APAC Recombinant Antibodies (rAbs) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Recombinant Antibodies (rAbs) by Country
7.1.1 Europe Recombinant Antibodies (rAbs) Sales by Country (2016-2021)
7.1.2 Europe Recombinant Antibodies (rAbs) Revenue by Country (2016-2021)
7.2 Europe Recombinant Antibodies (rAbs) Sales by Type
7.3 Europe Recombinant Antibodies (rAbs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Recombinant Antibodies (rAbs) by Country
8.1.1 Middle East & Africa Recombinant Antibodies (rAbs) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Recombinant Antibodies (rAbs) Revenue by Country (2016-2021)
8.2 Middle East & Africa Recombinant Antibodies (rAbs) Sales by Type
8.3 Middle East & Africa Recombinant Antibodies (rAbs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Recombinant Antibodies (rAbs) Distributors
10.3 Recombinant Antibodies (rAbs) Customer

11 Global Recombinant Antibodies (rAbs) Market Forecast
11.1 Global Recombinant Antibodies (rAbs) Forecast by Region
11.1.1 Global Recombinant Antibodies (rAbs) Forecast by Regions (2021-2026)
11.2.2 Global Recombinant Antibodies (rAbs) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Recombinant Antibodies (rAbs) Forecast by Type
11.7 Global Recombinant Antibodies (rAbs) Forecast by Application

12 Key Players Analysis
12.1 Abcam
12.1.1 Abcam Company Information
12.1.2 Abcam Recombinant Antibodies (rAbs) Product Offered
12.1.3 Abcam Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Abcam Main Business Overview
12.1.5 Abcam Latest Developments
12.2 Abeomics
12.2.1 Abeomics Company Information
12.2.2 Abeomics Recombinant Antibodies (rAbs) Product Offered
12.2.3 Abeomics Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abeomics Main Business Overview
12.2.5 Abeomics Latest Developments
12.3 Abnova Corporation
12.3.1 Abnova Corporation Company Information
12.3.2 Abnova Corporation Recombinant Antibodies (rAbs) Product Offered
12.3.3 Abnova Corporation Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Abnova Corporation Main Business Overview
12.3.5 Abnova Corporation Latest Developments
12.4 Absolute Antibody
12.4.1 Absolute Antibody Company Information
12.4.2 Absolute Antibody Recombinant Antibodies (rAbs) Product Offered
12.4.3 Absolute Antibody Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Absolute Antibody Main Business Overview
12.4.5 Absolute Antibody Latest Developments
12.5 Activity Signaling
12.5.1 Activity Signaling Company Information
12.5.2 Activity Signaling Recombinant Antibodies (rAbs) Product Offered
12.5.3 Activity Signaling Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Activity Signaling Main Business Overview
12.5.5 Activity Signaling Latest Developments
12.6 AIVD Biotech
12.6.1 AIVD Biotech Company Information
12.6.2 AIVD Biotech Recombinant Antibodies (rAbs) Product Offered
12.6.3 AIVD Biotech Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 AIVD Biotech Main Business Overview
12.6.5 AIVD Biotech Latest Developments
12.7 Bio X Cell
12.7.1 Bio X Cell Company Information
12.7.2 Bio X Cell Recombinant Antibodies (rAbs) Product Offered
12.7.3 Bio X Cell Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bio X Cell Main Business Overview
12.7.5 Bio X Cell Latest Developments
12.8 BioLegend
12.8.1 BioLegend Company Information
12.8.2 BioLegend Recombinant Antibodies (rAbs) Product Offered
12.8.3 BioLegend Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 BioLegend Main Business Overview
12.8.5 BioLegend Latest Developments
12.9 Bio-Rad
12.9.1 Bio-Rad Company Information
12.9.2 Bio-Rad Recombinant Antibodies (rAbs) Product Offered
12.9.3 Bio-Rad Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Bio-Rad Main Business Overview
12.9.5 Bio-Rad Latest Developments
12.10 Bon Opus Biosciences
12.10.1 Bon Opus Biosciences Company Information
12.10.2 Bon Opus Biosciences Recombinant Antibodies (rAbs) Product Offered
12.10.3 Bon Opus Biosciences Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bon Opus Biosciences Main Business Overview
12.10.5 Bon Opus Biosciences Latest Developments
12.11 Creative Biolabs
12.11.1 Creative Biolabs Company Information
12.11.2 Creative Biolabs Recombinant Antibodies (rAbs) Product Offered
12.11.3 Creative Biolabs Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Creative Biolabs Main Business Overview
12.11.5 Creative Biolabs Latest Developments
12.12 Creative Diagnostics
12.12.1 Creative Diagnostics Company Information
12.12.2 Creative Diagnostics Recombinant Antibodies (rAbs) Product Offered
12.12.3 Creative Diagnostics Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Creative Diagnostics Main Business Overview
12.12.5 Creative Diagnostics Latest Developments
12.13 Enzo Life Sciences, Inc.
12.13.1 Enzo Life Sciences, Inc. Company Information
12.13.2 Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Product Offered
12.13.3 Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Enzo Life Sciences, Inc. Main Business Overview
12.13.5 Enzo Life Sciences, Inc. Latest Developments
12.14 GRP GmbH
12.14.1 GRP GmbH Company Information
12.14.2 GRP GmbH Recombinant Antibodies (rAbs) Product Offered
12.14.3 GRP GmbH Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 GRP GmbH Main Business Overview
12.14.5 GRP GmbH Latest Developments
12.15 HUABIO
12.15.1 HUABIO Company Information
12.15.2 HUABIO Recombinant Antibodies (rAbs) Product Offered
12.15.3 HUABIO Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 HUABIO Main Business Overview
12.15.5 HUABIO Latest Developments
12.16 Miltenyi Biotec
12.16.1 Miltenyi Biotec Company Information
12.16.2 Miltenyi Biotec Recombinant Antibodies (rAbs) Product Offered
12.16.3 Miltenyi Biotec Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Miltenyi Biotec Main Business Overview
12.16.5 Miltenyi Biotec Latest Developments
12.17 NSJ Bioreagents
12.17.1 NSJ Bioreagents Company Information
12.17.2 NSJ Bioreagents Recombinant Antibodies (rAbs) Product Offered
12.17.3 NSJ Bioreagents Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 NSJ Bioreagents Main Business Overview
12.17.5 NSJ Bioreagents Latest Developments
12.18 PROGEN
12.18.1 PROGEN Company Information
12.18.2 PROGEN Recombinant Antibodies (rAbs) Product Offered
12.18.3 PROGEN Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 PROGEN Main Business Overview
12.18.5 PROGEN Latest Developments
12.19 RevMab Biosciences USA, Inc.
12.19.1 RevMab Biosciences USA, Inc. Company Information
12.19.2 RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Product Offered
12.19.3 RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 RevMab Biosciences USA, Inc. Main Business Overview
12.19.5 RevMab Biosciences USA, Inc. Latest Developments
12.20 Signalway Antibody LLC
12.20.1 Signalway Antibody LLC Company Information
12.20.2 Signalway Antibody LLC Recombinant Antibodies (rAbs) Product Offered
12.20.3 Signalway Antibody LLC Recombinant Antibodies (rAbs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Signalway Antibody LLC Main Business Overview
12.20.5 Signalway Antibody LLC Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Recombinant Antibodies (rAbs) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Rabbit
Table 3. Major Players of Mouse
Table 4. Major Players of Goat
Table 5. Major Players of Others
Table 6. Global Recombinant Antibodies (rAbs) Sales by Type (2016-2021) & (L)
Table 7. Global Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
Table 8. Global Recombinant Antibodies (rAbs) Revenue by Type (2016-2021) & ($ million)
Table 9. Global Recombinant Antibodies (rAbs) Revenue Market Share by Type (2016-2021)
Table 10. Global Recombinant Antibodies (rAbs) Sale Price by Type (2016-2021)
Table 11. Global Recombinant Antibodies (rAbs) Sales by Application (2016-2021) & (L)
Table 12. Global Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Table 13. Global Recombinant Antibodies (rAbs) Value by Application (2016-2021)
Table 14. Global Recombinant Antibodies (rAbs) Revenue Market Share by Application (2016-2021)
Table 15. Global Recombinant Antibodies (rAbs) Sale Price by Application (2016-2021)
Table 16. Global Recombinant Antibodies (rAbs) Sales by Company (2019-2021) & (L)
Table 17. Global Recombinant Antibodies (rAbs) Sales Market Share by Company (2019-2021)
Table 18. Global Recombinant Antibodies (rAbs) Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Recombinant Antibodies (rAbs) Revenue Market Share by Company (2019-2021)
Table 20. Global Recombinant Antibodies (rAbs) Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Recombinant Antibodies (rAbs) Producing Area Distribution and Sales Area
Table 22. Players Recombinant Antibodies (rAbs) Products Offered
Table 23. Recombinant Antibodies (rAbs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Recombinant Antibodies (rAbs) Sales by Region (2016-2021) (L)
Table 27. Global Recombinant Antibodies (rAbs) Sales Market Share by Region (2016-2021)
Table 28. Global Recombinant Antibodies (rAbs) Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Recombinant Antibodies (rAbs) Revenue Market Share by Region (2016-2021)
Table 30. Americas Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L)
Table 31. Americas Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021)
Table 32. Americas Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021)
Table 34. Americas Recombinant Antibodies (rAbs) Sales by Type (2016-2021) & (L)
Table 35. Americas Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
Table 36. Americas Recombinant Antibodies (rAbs) Sales by Application (2016-2021) & (L)
Table 37. Americas Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Table 38. APAC Recombinant Antibodies (rAbs) Sales by Region (2016-2021) & (L)
Table 39. APAC Recombinant Antibodies (rAbs) Sales Market Share by Region (2016-2021)
Table 40. APAC Recombinant Antibodies (rAbs) Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Recombinant Antibodies (rAbs) Revenue Market Share by Region (2016-2021)
Table 42. APAC Recombinant Antibodies (rAbs) Sales by Type (2016-2021) & (L)
Table 43. APAC Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
Table 44. APAC Recombinant Antibodies (rAbs) Sales by Application (2016-2021) & (L)
Table 45. APAC Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Table 46. Europe Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L)
Table 47. Europe Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021)
Table 48. Europe Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021)
Table 50. Europe Recombinant Antibodies (rAbs) Sales by Type (2016-2021) & (L)
Table 51. Europe Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
Table 52. Europe Recombinant Antibodies (rAbs) Sales by Application (2016-2021) & (L)
Table 53. Europe Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L)
Table 55. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Recombinant Antibodies (rAbs) Sales by Type (2016-2021) & (L)
Table 59. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Recombinant Antibodies (rAbs) Sales by Application (2016-2021) & (L)
Table 61. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Recombinant Antibodies (rAbs)
Table 63. Key Application and Potential Industries of Recombinant Antibodies (rAbs)
Table 64. Key Challenges of Recombinant Antibodies (rAbs)
Table 65. Key Trends of Recombinant Antibodies (rAbs)
Table 66. Recombinant Antibodies (rAbs) Distributors List
Table 67. Recombinant Antibodies (rAbs) Customer List
Table 68. Global Recombinant Antibodies (rAbs) Sales Forecast by Region (2021-2026) & (L)
Table 69. Global Recombinant Antibodies (rAbs) Consumption Market Forecast by Region
Table 70. Global Recombinant Antibodies (rAbs) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Recombinant Antibodies (rAbs) Sales Forecast by Country (2021-2026) & (L)
Table 73. Americas Recombinant Antibodies (rAbs) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Recombinant Antibodies (rAbs) Sales Forecast by Region (2021-2026) & (L)
Table 75. APAC Recombinant Antibodies (rAbs) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Recombinant Antibodies (rAbs) Sales Forecast by Country (2021-2026) & (L)
Table 77. Europe Recombinant Antibodies (rAbs) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Recombinant Antibodies (rAbs) Sales Forecast by Country (2021-2026) & (L)
Table 79. Middle East & Africa Recombinant Antibodies (rAbs) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Recombinant Antibodies (rAbs) Sales Forecast by Type (2021-2026) & (L)
Table 81. Global Recombinant Antibodies (rAbs) Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Recombinant Antibodies (rAbs) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Recombinant Antibodies (rAbs) Sales Forecast by Application (2021-2026) & (L)
Table 85. Global Recombinant Antibodies (rAbs) Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Recombinant Antibodies (rAbs) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Application (2021-2026)
Table 88. Abcam Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 89. Abcam Recombinant Antibodies (rAbs) Product Offered
Table 90. Abcam Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 91. Abcam Main Business
Table 92. Abcam Latest Developments
Table 93. Abeomics Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 94. Abeomics Recombinant Antibodies (rAbs) Product Offered
Table 95. Abeomics Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 96. Abeomics Main Business
Table 97. Abeomics Latest Developments
Table 98. Abnova Corporation Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 99. Abnova Corporation Recombinant Antibodies (rAbs) Product Offered
Table 100. Abnova Corporation Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 101. Abnova Corporation Main Business
Table 102. Abnova Corporation Latest Developments
Table 103. Absolute Antibody Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 104. Absolute Antibody Recombinant Antibodies (rAbs) Product Offered
Table 105. Absolute Antibody Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 106. Absolute Antibody Main Business
Table 107. Absolute Antibody Latest Developments
Table 108. Activity Signaling Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 109. Activity Signaling Recombinant Antibodies (rAbs) Product Offered
Table 110. Activity Signaling Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 111. Activity Signaling Main Business
Table 112. Activity Signaling Latest Developments
Table 113. AIVD Biotech Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 114. AIVD Biotech Recombinant Antibodies (rAbs) Product Offered
Table 115. AIVD Biotech Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 116. AIVD Biotech Main Business
Table 117. AIVD Biotech Latest Developments
Table 118. Bio X Cell Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 119. Bio X Cell Recombinant Antibodies (rAbs) Product Offered
Table 120. Bio X Cell Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 121. Bio X Cell Main Business
Table 122. Bio X Cell Latest Developments
Table 123. BioLegend Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 124. BioLegend Recombinant Antibodies (rAbs) Product Offered
Table 125. BioLegend Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 126. BioLegend Main Business
Table 127. BioLegend Latest Developments
Table 128. Bio-Rad Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 129. Bio-Rad Recombinant Antibodies (rAbs) Product Offered
Table 130. Bio-Rad Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 131. Bio-Rad Main Business
Table 132. Bio-Rad Latest Developments
Table 133. Bon Opus Biosciences Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 134. Bon Opus Biosciences Recombinant Antibodies (rAbs) Product Offered
Table 135. Bon Opus Biosciences Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 136. Bon Opus Biosciences Main Business
Table 137. Bon Opus Biosciences Latest Developments
Table 138. Creative Biolabs Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 139. Creative Biolabs Recombinant Antibodies (rAbs) Product Offered
Table 140. Creative Biolabs Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 141. Creative Biolabs Main Business
Table 142. Creative Biolabs Latest Developments
Table 143. Creative Diagnostics Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 144. Creative Diagnostics Recombinant Antibodies (rAbs) Product Offered
Table 145. Creative Diagnostics Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 146. Creative Diagnostics Main Business
Table 147. Creative Diagnostics Latest Developments
Table 148. Enzo Life Sciences, Inc. Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 149. Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Product Offered
Table 150. Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 151. Enzo Life Sciences, Inc. Main Business
Table 152. Enzo Life Sciences, Inc. Latest Developments
Table 153. GRP GmbH Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 154. GRP GmbH Recombinant Antibodies (rAbs) Product Offered
Table 155. GRP GmbH Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 156. GRP GmbH Main Business
Table 157. GRP GmbH Latest Developments
Table 158. HUABIO Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 159. HUABIO Recombinant Antibodies (rAbs) Product Offered
Table 160. HUABIO Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 161. HUABIO Main Business
Table 162. HUABIO Latest Developments
Table 163. Miltenyi Biotec Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 164. Miltenyi Biotec Recombinant Antibodies (rAbs) Product Offered
Table 165. Miltenyi Biotec Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 166. Miltenyi Biotec Main Business
Table 167. Miltenyi Biotec Latest Developments
Table 168. NSJ Bioreagents Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 169. NSJ Bioreagents Recombinant Antibodies (rAbs) Product Offered
Table 170. NSJ Bioreagents Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 171. NSJ Bioreagents Main Business
Table 172. NSJ Bioreagents Latest Developments
Table 173. PROGEN Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 174. PROGEN Recombinant Antibodies (rAbs) Product Offered
Table 175. PROGEN Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 176. PROGEN Main Business
Table 177. PROGEN Latest Developments
Table 178. RevMab Biosciences USA, Inc. Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 179. RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Product Offered
Table 180. RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 181. RevMab Biosciences USA, Inc. Main Business
Table 182. RevMab Biosciences USA, Inc. Latest Developments
Table 183. Signalway Antibody LLC Basic Information, Recombinant Antibodies (rAbs) Manufacturing Base, Sales Area and Its Competitors
Table 184. Signalway Antibody LLC Recombinant Antibodies (rAbs) Product Offered
Table 185. Signalway Antibody LLC Recombinant Antibodies (rAbs) Sales (L), Revenue ($ Million), Price (US$/ul) and Gross Margin (2019-2021E)
Table 186. Signalway Antibody LLC Main Business
Table 187. Signalway Antibody LLC Latest Developments
List of Figures
Figure 1. Picture of Recombinant Antibodies (rAbs)
Figure 2. Recombinant Antibodies (rAbs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2026 (L)
Figure 7. Global Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Recombinant Antibodies (rAbs) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Rabbit
Figure 10. Product Picture of Mouse
Figure 11. Product Picture of Goat
Figure 12. Product Picture of Others
Figure 13. Global Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020
Figure 14. Global Recombinant Antibodies (rAbs) Revenue Market Share by Type (2016-2021)
Figure 15. Recombinant Antibodies (rAbs) Consumed in Hospitals & Diagnostic Laboratories
Figure 16. Global Recombinant Antibodies (rAbs) Market: Hospitals & Diagnostic Laboratories (2016-2021) & (L)
Figure 17. Recombinant Antibodies (rAbs) Consumed in Pharmaceutical & Biotechnology
Figure 18. Global Recombinant Antibodies (rAbs) Market: Pharmaceutical & Biotechnology (2016-2021) & (L)
Figure 19. Recombinant Antibodies (rAbs) Consumed in Research Institutes
Figure 20. Global Recombinant Antibodies (rAbs) Market: Research Institutes (2016-2021) & (L)
Figure 21. Recombinant Antibodies (rAbs) Consumed in Others
Figure 22. Global Recombinant Antibodies (rAbs) Market: Others (2016-2021) & (L)
Figure 23. Global Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021)
Figure 24. Global Recombinant Antibodies (rAbs) Revenue Market Share by Application in 2020
Figure 25. Recombinant Antibodies (rAbs) Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Recombinant Antibodies (rAbs) Revenue Market Share by Company in 2020
Figure 27. Global Recombinant Antibodies (rAbs) Sales Market Share by Regions (2016-2021)
Figure 28. Global Recombinant Antibodies (rAbs) Revenue Market Share by Region in 2020
Figure 29. Americas Recombinant Antibodies (rAbs) Sales 2016-2021 (L)
Figure 30. Americas Recombinant Antibodies (rAbs) Revenue 2016-2021 ($ Millions)
Figure 31. APAC Recombinant Antibodies (rAbs) Sales 2016-2021 (L)
Figure 32. APAC Recombinant Antibodies (rAbs) Revenue 2016-2021 ($ Millions)
Figure 33. Europe Recombinant Antibodies (rAbs) Sales 2016-2021 (L)
Figure 34. Europe Recombinant Antibodies (rAbs) Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Recombinant Antibodies (rAbs) Sales 2016-2021 (L)
Figure 36. Middle East & Africa Recombinant Antibodies (rAbs) Revenue 2016-2021 ($ Millions)
Figure 37. Americas Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020
Figure 38. Americas Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020
Figure 39. Americas Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020
Figure 40. Americas Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020
Figure 41. United States Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Recombinant Antibodies (rAbs) Sales Market Share by Region in 2020
Figure 46. APAC Recombinant Antibodies (rAbs) Revenue Market Share by Regions in 2020
Figure 47. APAC Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020
Figure 48. APAC Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020
Figure 49. China Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020
Figure 56. Europe Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020
Figure 57. Europe Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020
Figure 58. Europe Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020
Figure 59. Germany Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020
Figure 68. Egypt Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Recombinant Antibodies (rAbs) Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


★調査レポート[世界の組換え抗体（rAbs）市場予測 2021年-2026年] (コード：LPI21MY9565)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換え抗体（rAbs）市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアンチトロンビン（組換え）市場予測 2021年-2026年
    LPI21MY9424 / LP Information / 2021年5月 / LPインフォメーション社の「アンチトロンビン（組換え）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、凍結乾燥製剤、凍結乾燥粉末など、用途別には、病院、クリニックなどにセグメント区分してまとめました。アンチトロンビン（組換え）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アンチトロンビン（組換え）の世界市場概要（サマリー） ・アンチトロンビン（組換え）の企業別販売量・売上 ・アンチトロンビン（組換え）の企業別市場シェア ・アンチトロンビン（組換え）の世界市場規模 2016年-2021年：種類別（凍結乾燥製剤、凍結乾燥粉末） ・アンチトロンビン（組換え）の世界市場規模 2016年-2021年：用途別（病院、クリニック） ・アンチトロンビン（組換え）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アンチトロンビン（組換え）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Antithrombin (Recombinant) will have significant change from previous year. By the most conservative estimates of global Antithrombin (Recombinant) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antithrombin (Recombinant) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antithrombin (Recombinant) market by product type, application, key manufacturers and...
  • 世界のフォンウィルブランド因子（組換え）市場予測 2021年-2026年
    LPI21MY9690 / LP Information / 2021年5月 / LPインフォメーション社の「フォンウィルブランド因子（組換え）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、650IU、 1300IUなど、用途別には、病院、クリニックなどにセグメント区分してまとめました。フォンウィルブランド因子（組換え）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・フォンウィルブランド因子（組換え）の世界市場概要（サマリー） ・フォンウィルブランド因子（組換え）の企業別販売量・売上 ・フォンウィルブランド因子（組換え）の企業別市場シェア ・フォンウィルブランド因子（組換え）の世界市場規模 2016年-2021年：種類別（650IU、 1300IU） ・フォンウィルブランド因子（組換え）の世界市場規模 2016年-2021年：用途別（病院、クリニック）...According to this latest study, the 2021 growth of von Willebrand Factor (Recombinant) will have significant change from previous year. By the most conservative estimates of global von Willebrand Factor (Recombinant) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the von Willebrand Factor (Recombinant) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of von Willebrand Factor (Recombinant)...
  • 世界の幹細胞研究製品市場予測 2021年-2026年
    LPI21MY9677 / LP Information / 2021年5月 / LPインフォメーション社の「幹細胞研究製品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。幹細胞研究製品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・幹細胞研究製品の世界市場概要（サマリー） ・幹細胞研究製品の企業別販売量・売上 ・幹細胞研究製品の企業別市場シェア ・幹細胞研究製品の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・幹細胞研究製品の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・幹細胞研究製品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・幹細胞研究製品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Trial Size Antibodies will have significant change from previous year. By the most conservative estimates of global Trial Size Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Trial Size Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Trial Size Antibodies market by product type,...
  • 世界の組換えペプチド市場予測 2021年-2026年
    LPI21MY9566 / LP Information / 2021年5月 / LPインフォメーション社の「組換えペプチドの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、グルカゴン、カルシトニン、その他など、用途別には、腫瘍、血液疾患、感染症、自己免疫疾患、その他などにセグメント区分してまとめました。組換えペプチドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・組換えペプチドの世界市場概要（サマリー） ・組換えペプチドの企業別販売量・売上 ・組換えペプチドの企業別市場シェア ・組換えペプチドの世界市場規模 2016年-2021年：種類別（グルカゴン、カルシトニン、その他） ・組換えペプチドの世界市場規模 2016年-2021年：用途別（腫瘍、血液疾患、感染症、自己免疫疾患、その他） ・組換えペプチドの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・組換えペプチドのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Recombinant Peptide will have significant change from previous year. By the most conservative estimates of global Recombinant Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Recombinant Peptide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Peptide market by product type, application, key manufacturers and...
  • 世界のモノクローナル抗体市場予測 2021年-2026年
    LPI21MY9592 / LP Information / 2021年5月 / LPインフォメーション社の「モノクローナル抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、がん、自己免疫疾患、感染症、血液疾患、その他など、用途別には、腫瘍、自己免疫＆炎症性疾患、呼吸器疾患、眼科などにセグメント区分してまとめました。モノクローナル抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・モノクローナル抗体の世界市場概要（サマリー） ・モノクローナル抗体の企業別販売量・売上 ・モノクローナル抗体の企業別市場シェア ・モノクローナル抗体の世界市場規模 2016年-2021年：種類別（がん、自己免疫疾患、感染症、血液疾患、その他） ・モノクローナル抗体の世界市場規模 2016年-2021年：用途別（腫瘍、自己免疫＆炎症性疾患、呼吸器疾患、眼科） ・モノクローナル抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・モノクローナル抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Monoclonal Antibodies will have significant change from previous year. By the most conservative estimates of global Monoclonal Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Monoclonal Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies market by product type, application, key manufacturers and...
  • 世界の連鎖状球菌肺炎抗体市場予測 2021年-2026年
    LPI21MY9664 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌肺炎抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌肺炎抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌肺炎抗体の世界市場概要（サマリー） ・連鎖状球菌肺炎抗体の企業別販売量・売上 ・連鎖状球菌肺炎抗体の企業別市場シェア ・連鎖状球菌肺炎抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌肺炎抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌肺炎抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌肺炎抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Pneumoniae Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Pneumoniae Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Pneumoniae Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Antibodies market by product type,...
  • 世界の連鎖状球菌グループA抗体市場予測 2021年-2026年
    LPI21MY9662 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌グループA抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌グループA抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌グループA抗体の世界市場概要（サマリー） ・連鎖状球菌グループA抗体の企業別販売量・売上 ・連鎖状球菌グループA抗体の企業別市場シェア ・連鎖状球菌グループA抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌グループA抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌グループA抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌グループA抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Group A Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Group A Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Group A Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Group A Antibodies...
  • 世界のクラミジアトラコマチス抗体市場予測 2021年-2026年
    LPI21MY9479 / LP Information / 2021年5月 / LPインフォメーション社の「クラミジアトラコマチス抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオテクノロジー、研究機関、その他などにセグメント区分してまとめました。クラミジアトラコマチス抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・クラミジアトラコマチス抗体の世界市場概要（サマリー） ・クラミジアトラコマチス抗体の企業別販売量・売上 ・クラミジアトラコマチス抗体の企業別市場シェア ・クラミジアトラコマチス抗体の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・クラミジアトラコマチス抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオテクノロジー、研究機関、その他） ・クラミジアトラコマチス抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・クラミジアトラコマチス抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Chlamydia Trachomatis Antibodies will have significant change from previous year. By the most conservative estimates of global Chlamydia Trachomatis Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Chlamydia Trachomatis Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Chlamydia Trachomatis Antibodies market by product type,...
  • 世界の連鎖状球菌グループB抗体市場予測 2021年-2026年
    LPI21MY9663 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌グループB抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌グループB抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌グループB抗体の世界市場概要（サマリー） ・連鎖状球菌グループB抗体の企業別販売量・売上 ・連鎖状球菌グループB抗体の企業別市場シェア ・連鎖状球菌グループB抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌グループB抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌グループB抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌グループB抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Group B Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Group B Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Group B Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Group B Antibodies...
  • 世界の結核菌抗体市場予測 2021年-2026年
    LPI21MY9597 / LP Information / 2021年5月 / LPインフォメーション社の「結核菌抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオテクノロジー、研究所、その他などにセグメント区分してまとめました。結核菌抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・結核菌抗体の世界市場概要（サマリー） ・結核菌抗体の企業別販売量・売上 ・結核菌抗体の企業別市場シェア ・結核菌抗体の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・結核菌抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオテクノロジー、研究所、その他） ・結核菌抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・結核菌抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Mycobacterium Tuberculosis Antibodies will have significant change from previous year. By the most conservative estimates of global Mycobacterium Tuberculosis Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Mycobacterium Tuberculosis Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Mycobacterium Tuberculosis Antibodies market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆